Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia

Eur Respir J. 2018 Mar 22;51(3):1702550. doi: 10.1183/13993003.02550-2017. Print 2018 Mar.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / adverse effects
  • Clinical Trials as Topic
  • Diarylquinolines / administration & dosage*
  • Diarylquinolines / adverse effects
  • Drug Administration Schedule
  • France
  • Humans
  • Latvia
  • Male
  • Nitroimidazoles / administration & dosage*
  • Nitroimidazoles / adverse effects
  • Oxazoles / administration & dosage*
  • Oxazoles / adverse effects
  • Patient Safety
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • bedaquiline